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ABSTRACT
Terminalia bellerica has been used as a folk medicine in a variety of ailments including hypertension. Our aim was to investigate the possible mechanism of its blood pressure (BP)-lowering effect. The crude extract of Terminalia bellerica fruit (Tb.Cr)
which tested positive for flavonoids, sterols and tannins induced a dose-dependent (10-100 mg/kg) fall in the arterial BP of rats
under anaesthesia. In isolated guinea-pig atria, Tb.Cr inhibited the force and rate of atrial contractions. In rabbit thoracic aorta,
Tb.Cr relaxed the phenylephrine (PE, 1 μM) and K+ (80 mM)-induced contractions as well as suppressed the PE (1 μM) control
peaks in the Ca++-free medium, similar to that caused by verapamil. The vasodilator effect of Tb.Cr was endothelium-independent
as it was not opposed by Nω -nitro-L-arginine methyl ester in endothelium-intact rat aortic preparations and it occurred at the similar
concentration in the endothelium-denuded tissues. These results indicate that Terminalia bellerica lowers BP through Ca++ antagonist mechanism and thus provides a sound mechanistic background for its medicinal use in hypertension.
Key words: Terminalia bellerica, antihypertensive, Ca++ antagonist

INTRODUCTION
Terminalia bellerica Roxb. (family: Combretaceae), commonly known as belleric myrobalan and locally
known as bahera, is an edible plant found throughout
Central Asia (1). Its fruit has been used in traditional
medial system for anemia, asthma, cancer, colic, constipation, diarrhoea, dysuria, headache, hypertension,
inﬂammations, and rheumatism(2,3). It contains termilignan, thannilignan, 7-hydroxy-3´,4´-(methylenedioxy)
ﬂavone, anolignan B(4), gallic acid, ellagic acid, ß-sitosterol(5), arjungenin, belleric acid, bellericoside (6) and
cannogenol
3-O-ß-D-galactopyranosyl-(1→4)-O-α-Lrhamnopyranoside (7).
Terminalia bellerica is known to lower the lipid levels
in hypercholesterolemic animals(8). The ethanolic extract
of Terminalia bellerica was found effective against several
pathogens including Bacillus subtilis, Proteus vulgaris,
Salmonella typhimurium, Salmonella typhimurium, Escherichia coli, and Staphylococcus aureus(9). Terminalia
bellerica exhibited inhibitory effect on human immunodeﬁciency virus-1 reverse transcriptase (10). The leaves
and fruits of Terminalia bellerica showed antioxidant
* Author for correspondence. Tel: +92-21-4864571;
Fax: +92-21-493-4294, +92-21-493-2095;
E-mail: anwar.gilani@aku.edu

activity(11). On the other hand, methanolic extract (75%)
of Terminalia bellerica reduced the serum glucose level
both in normal and alloxan-induced diabetic rats(12), showing preventive effect against the myocardial necrosis in
rats(13). A water soluble fraction obtained from the defatted fruits of Terminalia bellerica caused hepatoprotection
against CCl4 -induced hepatotoxicity(14).
Srivastava et al.(15) and Dwivedi et al.(16) reported
that Terminalia bellerica lowers blood pressure (BP) but
the precise mode of action remains to be elucidated. In
this study, we explored the mechanism underlying its
hypotensive effect. The present report further supports
the previous ﬁndings on the use of Terminalia bellerica
as an antihypertensive agent.

MATERIALS AND METHODS
I. Plant Material and Extraction
Fruits of Terminalia bellerica were bought at a local
market in Dhaka (Bangladesh) and the sample voucher
(TB-FR-10-95-30) was submitted to the herbarium of the
Department of Biological and Biomedical Sciences, Aga
Khan University, Karachi. After cleaning of adulterant
material, 432 g of the fruits were crushed and soaked in
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the 70% aqueous-methanol for three days with vigorous shaking. The mixture was ﬁltered through a muslin
cloth and then through a Whatman qualitative grade 1
ﬁlter paper (17). This procedure was repeated thrice and
the combined ﬁltrate was evaporated on rotary evaporator under reduced pressure to a semi-solid mass of brown
colour, i.e. the crude extract (Tb.Cr), yielding approximately 9.25%. Tb.Cr was completely solubilized both in
distilled water and saline for experimental use in vitro
and in vivo.
II. Drugs and Animals
The following reference chemicals were obtained
from the sources speciﬁed: acetylcholine chloride (ACh),
Nω -nitro-L-arginine methyl ester hydrochloride (LNAME), phenylephrine hydrochloride (PE) and verapamil hydrochloride (Sigma Chemical Company, St.
Louis, MO, USA). Thiopental sodium and heparin injections were purchased from Abbot Laboratories, Karachi,
Pakistan and Rotex Medica, Trittau, Germany, respectively. The following chemicals were used to make the
physiological salt solutions: potassium chloride (Sigma
Chemical Company, St. Louis, MO, USA), calcium chloride, glucose, magnesium chloride, magnesium sulphate,
potassium dihydrogen phosphate, sodium bicarbonate,
sodium chloride, sodium dihydrogen phosphate (Merck,
Darmstadt, Germany) and ethylenediaminetetra acetic
acid (BDH Laboratory Supplies, Poole, England). All
chemicals were of analytical grade. Stock solutions of the
drugs were made in distilled H 2O/saline and subsequent
dilutions were prepared fresh on the day of experiment.
Animals used in this study such as Sprague-Dawley
rats (180-200 g), guinea-pigs (450-500 g) and rabbits (11.5 kg) of either sex and local breed were housed at the
Aga Khan University animal house under a standard diet
and tap water ad labitum in a controlled environment
(23-25°C). Experiments performed complied with the
rulings of the Institute of Laboratory Animal Resources,
Commission on Life Sciences, National Research Council(18) and approved by the Ethical Committee of the Aga
Khan University.

paper impregnated with the vapours from boiling extract
indicated the presence of coumarins. Benzene extract
prepared from acidiﬁed plant material was treated with
NH4OH for anthraquinones based on the appearance of
pink, violet or red colour. The total phenolic and ﬂavonoid contents were determined according to Singleton et
al.(22) and Huang et al.(23) respectively.
IV. Measurement of BP in Anaesthetized Rats
Measurements were taken according to the method
previously described (24). Rats were anaesthetized with
thiopental sodium (Pentothal®, 70-90 mg/kg, i.p.) and the
arterial BP was recorded through carotid artery cannulation via pressure transducer (P23 XL) coupled with a
Grass model 7 Polygraph (Grass instrument company,
Quincy, MA, USA). Drugs were administered through
a cannula inserted into the jugular vein. After 20 min of
equilibrium, the rats were injected with 0.1 mL of saline
(NaCl 0.9%) or with the same volume of test substance.
Arterial BP was allowed to return to the initial level
between injections. Changes in BP were recognized as
differences between the steady state before injection and
the lowest readings after injection. Mean arterial blood
pressure (MABP) was calculated as the diastolic BP plus
one-third pulse width.
V. Guinea-pig Atria
Right atria isolated from the guinea-pigs killed by
cervical dislocation, were mounted individually in 20 mL
of tissue bath containing Kreb’s solution(25) at 32°C and
aerated with carbogen (5% CO2 in O2). Composition of
the Kreb’s solution was (mM): NaCl 118.2, NaHCO3 25.0,
CaCl 2 2.5, KCl 4.7, KH 2PO 4 1.3, MgSO 4 1.2 and glucose
11.7 (pH 7.4). The tissues were allowed to beat spontaneously (due to pacemaker) under the resting tension of 1
g. An equilibrium period of 30 min was given before the
application of any drug. Tension changes in the tissue
were recorded via force-displacement transducer (model
FT-03) using Grass Model 7 Polygraph.
VI. Rabbit Aorta

III. Phytochemical Analysis
Preliminary screening of the plant extract for various
phytochemical classes was carried out based on a modiﬁed version of the reported methods (19-21). Alkaloids
were tested using Dragendorff’s reagent. Yellow colour
with AlCl 3 reagent and green or black colour with aqueous FeCl 3 detected ﬂavonoids and tannins respectively.
Plant material treated with petroleum ether and extracted
with CHCl 3 was noted for green to pink or pink to purple
colour after reaction with acetic anhydride and HCl to
detect sterols and terpenes respectively. Saponins were
detected on the basis of froth upon vigorous shaking. The
observation of yellow ﬂorescence under UV light on ﬁlter

Rabbit descending thoracic aorta was removed and
cut into 2-3 mm wide rings which were mounted individually in 20 mL of tissue bath containing Kreb’s solution
at 37°C and supplied with carbogen(26). A basal tension
of 2 g was applied to each tissue. After 1 hr of equilibrium period, the tissues stabilized with a ﬁxed concentration of PE (1 μM). Changes in isometric tensions of the
rings were measured via FT-03 transducer using Grass
Model 7 Polygraph. The extract was tested for its ability
to relax the contractions induced with PE (1 μM) or high
K+ (80 mM). The inhibition of PE and high K+-induced
sustained contractions indicated a blockade of Ca++
inﬂux through membrane bound receptor-operated and
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voltage-sensitive calcium channels, respectively(27,28).
The plant material was than tested against PE (1 μM)evoked peaks in the Ca++ -free Kreb’s solution to observe
its effect on the intracellular stores. As in the Ca++ -free
medium, PE acts through stimulation of α1-adrenergic
receptors and then the consequent conversion of phosphatidylinositol to inositol-1,4,5-triphosphate which releases
Ca++ from the sarcoplasmic reticulum resulting in a tonic
contraction(29,30).
VII. Rat Aorta
The procedure of Furchgott and Zawadski(31) was
followed with some modiﬁcations. Thoracic aorta was
isolated from the rat and cut into the rings, which were
mounted individually in 5 mL of tissue bath, maintained at 37°C and aerated with carbogen. A preload of
1 g was applied to each preparation and incubated for
30 min. Changes in tension were recorded and analyzed
isometrically through a force transducer (Fort-10, WPI,
UK) coupled to a bridge ampliﬁer (Transbridge TBM
4M, WPI) and PowerLab ML 845 data acquisition system
(AD Instruments, Sydney, Australia). The tissues were
than stabilized with PE (1 μM). After stabilization, an
induced contraction was obtained with PE (1 μM). Once
plateau was achieved, ACh (0.3 μM) was than tested on
PE-induced contraction to observe the endothelium integrity. The endothelium lining of the tissues was removed
by gentle rubbing, which resulted in the disappearance of
the relaxation caused by ACh in the endothelium-intact
preparations.
VIII. Statistical Analysis

tracing from a typical experiment, whereas the combined
data from different experiments is plotted in Figure 1B.
Pre-treatment of animals with atropine (1 mg/kg) did not
alter the effect of Tb.Cr (data not shown).
III. Effect on Guinea-pig Atria
In isolated guinea-pig atria, Tb.Cr exhibited a
concentration-dependent inhibitory effect on the atrial
force and rate of contractions (Figure 2A) with respective EC50 values of 4.5 ± 1.2 and 5.9 ± 1.3 mg/mL (Figure
2B). Similarly, verapamil caused concentration-dependent inhibitory effect with EC50 values of 0.7 ± 1.2 and
1.0 ± 1.2 μM respectively (Figure 2 A and C).
IV. Effect on Rabbit Aorta
When tested on the resting base line of rabbit aorta,
the extract was devoid of vasoconstrictor effect up to 10

(A)

(B)

Data were expressed as mean ± standard error of
mean (SEM, n = number of experiment). The statistical parameter applied was one-way ANOVA followed
by Tukey test using GraphPad program (GraphPAD, San
Diego, CA, USA). P < 0.05 was considered statistically
signiﬁcant. Concentration-response curves were analyzed
by non-linear regression (GraphPAD program).

RESULTS
I. Phytochemical Screening
Tb.Cr was tested positive for ﬂavonoids, sterols
and tannins while negative for the rest of classes. Total
phenolic and ﬂavonoid contents were 258.4 ± 5.8 and 11.0
± 0.4 mg of quercetin equivalent/g of Tb.Cr.
II. Effect on BP in Rats
Tb.Cr at the doses of 10, 30 and 100 mg/kg caused
a respective fall of 15.6 ± 2.0, 25.1 ± 2.3 and 44.7 ± 3.1%
in MABP of rats under anaesthesia. Figure 1A shows

Figure 1. Upper panel (A) shows the typical tracing of Terminalia
bellerica crude extract (Tb.Cr) for its blood pressure lowering effect
and lower panel (B) shows the effect of Tb.Cr on mean arterial blood
pressure (MABP) in anesthetized rats. The dose was administered
after response of the preceding one returned to the normal. Symbols
represent mean ± SEM, n = 4.
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Figure 2. Upper panel (A) shows typical tracing of the cardiodepressant effect of Terminalia bellerica crude extract (Tb.Cr) in
comparison to verapamil and the lower panels (B) and (C) represent
concentration-response curves showing the inhibitory effect of Tb.Cr
and verapamil on the atrial force and rate of contractions in isolated
guinea-pig right atria. Symbols represent mean ± SEM, n = 4.

mg/mL. Tb.Cr relaxed the PE (1 μM) and K+ (80 mM)induced contractions with respective EC50 values of 6.4 ±
1.3 and 7.5 ± 1.3 mg/mL. Verapamil was also free of any
vasoconstrictor effect and inhibited the PE (1 μM) and
K+ (80 mM)-induced contractions with EC50 values of
1.2 ± 1.2 and 1.0 ± 1.2 μM respectively. Figure 3A shows
typical tracings, whereas the combined data from different experiments is presented in Figure 3B and C. In the
Ca++ -free medium, Tb.Cr and verapamil suppressed the
PE (1 μM) peak responses at the concentration ranges of
3-10 mg/mL and 0.03-0.3 μM respectively (Figure 4).
V. Effect on Rat Aorta
In endothelium-intact rat aortic rings, Tb.Cr concentration-dependently relaxed the PE (1 μM)-induced
contractions in absence of any intervention and in presence of L-NAME (0.1 mM) with respective EC50 values
of 3.5 ± 1.1 and 3.8 ± 1.2 mg/mL. In endothelium-denuded preparations, Tb.Cr relaxed the PE (1 μM)-induced

0
0.03

0.3

3

[Verapamil] μM

contractions with EC50 value of 3.01 ± 1.2 mg/mL. Verapamil inhibited these contractions with respective EC50
values of 7.1 ± 1.2, 5.6 ± 1.2 and 6.6 ± 1.3 μM (Figure 5).

DISCUSSION
The aqueous-methanolic extract of Terminalia
bellerica induced a dose-dependant fall in the BP of
normotensive rats under anaesthesia as expected. It is
customary to use isolated tissue preparations to evaluate
the underlying mechanism of action, as response interference from intact reﬂex is obliterated (32). BP is considered the product of cardiac output and peripheral resistance (33), hence the extract was further studied in isolated
heart and vascular preparations. In guinea-pig atria,
Tb.Cr exhibited a negative inotropic and chronotropic
effect, similar to that caused by verapamil, a standard
Ca++ channel blocker (34). Calcium antagonists are known
to cause cardiac depression through inhibiting the slow
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Figure 3. Typical tracings showing the relaxant effect of Terminalia bellerica crude extract (Tb.Cr) on phenylephrine (PE) and K+-induced
contractions in comparison to verapamil (A). (B) and (C) concentration-response curves representing the inhibitory effect of Tb.Cr and
verapamil on PE and K+ -induced contractions in isolated rabbit aortic ring preparations. Symbols represent mean ± SEM, n = 4-5.

inward current during the action potential plateau (35).
The cardiac inhibitory action of the extract may be due to
the Ca++ antagonist effect leading to decrease in cardiac
out put and thus falling BP.
The plant extract was tested in two different types of
vascular tissues. Rabbit aorta is routinely used for screening of Ca++ antagonists (36). Tb.Cr inhibited the high K+
and PE-induced contractions of rabbit aorta at similar
concentration, indicating that it was equipotently blocking the Ca++ inﬂux through voltage- and receptor-operated calcium channels (37). In addition to the Ca++ inﬂux
through membrane bound calcium channels, smooth
muscle contraction also occurs via Ca++ release from

the intracellular sarcoplasmic reticulum(38,39). When
control PE responses were obtained in the Ca++ free
medium, extract in increasing concentrations suppressed
the agonist peaks, thus inhibiting the Ca++ release from
the internal stores(40). The results were similar to those
obtained with verapamil.
The second type of vascular preparation used was
rat aorta, which is a prototype tissue for evaluating the
endothelium-dependent vasodilation(41). The vasodilator effect of Tb.Cr was endothelium-independent, evident
from the fact that its inhibitory effect on the endothelium-intact tissues was resistant to L-NAME, a nitric
oxide synthase inhibitor (42) and that the effect occurred
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Figure 4. Upper panel (A) shows typical tracings of the concentration-dependant suppressant effect of Terminalia bellerica crude extract (Tb.
Cr) and verapamil on control phenylephrine (PE) peaks in the Ca++ free Kreb’s solution while the lower panels (B) and (C) represent bar chart for
the inhibitory effect of Tb.Cr and verapamil on PE responses in isolated rabbit aortic ring preparations. Symbols represent mean ± SEM, n = 4.

in endothelium-denuded preparations at the same concentration, similar to the fashion of a standard Ca++ channel
blocker.

Terminalia bellerica extract was found to contain
ﬂavonoids, sterols and tannins. Flavonoids and tannins
are reported to possess Ca++ antagonist effect (43,44) and
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Figure 5. Upper panel (A) shows traces for the relaxant effect of Terminalia bellerica crude extract (Tb.Cr) and verapamil on phenylephrine
(PE)-induced contractions of endothelium (E)-intact aortic rings in the absence and presence of N ω -nitro-L-arginine methyl ester
hydrochloride (L-NAME) and E-denuded preparations. (B) and (C) shows concentration-response curves representing the inhibitory effect of
Tb.Cr and verapamil on PE-induced contractions in the absence () and presence of L-NAME (%) in E-intact and E-denuded (6) isolated rat
aorta preparations. Symbols represent mean ± SEM, n = 4-5. The curves were not signiﬁcantly different from each other (P > 0.05); one way
ANOVA.
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the presence of such compounds in Terminalia bellerica
might be contributing in its cardiovascular effects.

CONCLUSIONS

11.

This study showed that Terminalia bellerica exhibits
BP-lowering effect possibly mediated through inhibition
of Ca++ inﬂux via membranous calcium channels and its
release from the intracellular stores and thus explains its
medicinal use in hypertension.

12.

13.
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